The Latest Breaking News from Point72

Point72 increased its stake in Bill Holdings by over 180% amid rumours of a potential sale, as the cloud software firm faces declining revenues and stiff sector competition.

Billionaire Mets owner Steve Cohen's hedge fund, Point72, acquired over 10 million shares of Lionsgate Studios for $64 million just days before the company's fiscal Q2 earnings on 6th November.

Steven Cohen isn't afraid of volatility — and his latest moves show he's diving headfirst into small-cap biotech. The billionaire hedge fund manager's Point72 Asset Management has built new stakes in two clinical-stage companies, betting that their breakthroughs in genetic and antibody therapies could deliver outsized returns.

Point72 Asset Management recently purchased over 10 million shares of Confluent and Amylyx Pharma common stock, worth more than $334.17 million.

Billionaire investor Steve Cohen invested over $100 million in two biopharma stocks, one of which has rallied over 90% in the past one month.

Billionaire investor Steven A. Cohen opened new stock positions, including Amazon, AT&T, Netflix, Salesforce, and UnitedHealth Group in Q4.

The best traders are just like the best baseball players: “They can’t wait to work, even in the offseason.”

Steve Cohen recently revealed he is bullish on AI and believes it can significantly improve productivity in companies across industries.

Boeing has trimmed delivery and production of its 737 Max fleet, while Broadcom's quarterly revenue jumped 34% YoY on high chip demand for AI data centres.